ORDER A TEST Log In Contact Us
Hero Background

OMICS SOLUTIONS

High-throughput portfolio of multiple omics capabilities for holistic interrogation of the genome

Tempus offers a wide range of disease-agnostic technologies, including NGS, methylation testing, genotyping, proteomics, and single-cell sequencing, designed to support all phases from biomarker discovery to clinical development.

Contact Us
TESTING ACROSS LIFE SCIENCES SECTORS

Customizable solutions for your program needs

Our omics solutions can be tailored to meet various life sciences sectors’ unique requirements and specifications.

  • Researchers

    Enhance your research with integrated multi-omics data and insights.

  • Biopharma

    Accelerate target discovery and development with precise biomarker identification.

  • Direct to Consumer

    Access high-quality genomics data and personalized health insights for your platform.

    Learn more

Tempus Ecosystem

Our research use only (RUO) omics testing solutions, alongside our vast data repository, biological modeling solutions, and sequencing tests, can offer comprehensive insights for disease mechanism analysis and translational research. Tempus supports clinical development from biomarker discovery to companion diagnostic development as an end-to-end provider.

image description

Integrating multi-omics in R&D and clinical programs

Refine biomarker signatures and improve mechanisms of action (MOA) decisions with multiple omics datasets. Tempus offers the following testing capabilities with customizable workflows to meet your research goals.

image description

Our Solutions

Next-Generation Sequencing (NGS)

Tempus offers the full Illumina NGS suite of instruments, including NovaSeqX+ (Whole Genome/Exome/Transcriptome Sequencing)

  • Faster, powerful whole genome sequencing  (30x-200x)
  • Cost-effective Low Pass WGS, with or without imputation, delivering large data quantities
  • Whole exome and whole transcriptome sequencing with flexible coverage

Metagenomics

Our metagenomics technologies allow researchers to investigate microbiome communities

  • Supports microbiome analysis through shotgun or 16S and ITS rRNA sequencing
  • 16S rRNA sequencing analyzes the prokaryotic 16S ribosomal RNA gene (1500 bp), which contains 9 variable regions (species-specific)
  • ITS sequences a highly variable region of the fungal rRNA (ribosomal RNA) gene cluster, which can help identify and differentiate fungal species
  • Excellent resource for gut microbiome monitoring or ongoing research

Genotyping

Our wide portfolio of genotyping solutions fits the needs of small and high-volume projects:

Illumina

  • Medium-to-high throughput volumes
  • Multiple arrays for GWAS sample analysis
  • Custom array design available depending on project needs
  • Arrays and boosters for a wide variety of testing such as GSA, GDA, PGx booster and Neuro booster

Thermofisher

  • Medium-to-high throughput volumes
  • Enables GWAS, PGx, and Gene Expression analysis
  • Multiple sample formats

Methylation

As one of the highest-volume methylation testing laboratories in the country, we have robust methylation solutions with an optimized workflow for high-quality data

  • Extensive experience running Illumina Infinium EPIC 935k Bead Chip at a cost-effective price
  • Assay can provide data for research applications such as methylation profiling and biological age calculations
  • Supports data generation for EWAS analysis

Proteomics

Explore the proteome with our Olink and SomaLogic platforms*, designed for advanced biomarker discovery and multi-omic analysis. These technologies excel in measuring protein concentrations across various sample types, including plasma, serum, and more.

Olink Explore 3072

  • Quantify ~2,400 protein targets
  • Designed for high-throughput biomarker discovery
  • Optimal for exploratory proteomics and multi-omic studies
  • Access eight targeted 384-plex panels for disease-specific and biological process research**

Olink Explore HT

  • Measure ~5,400 protein targets
  • Achieve high specificity with minimal sample requirements
  • Equipped with user-friendly data tools, suitable for all project sizes
  • Employ a single-panel approach for efficient high-throughput analysis and a streamlined workflow

SomaLogic SomaScan

  • Asses ~6,000 protein targets
  • Utilize high-plex, high-throughput technology for extensive research
  • Gain access to a comprehensive dataset for in-depth proteomic biomarker analysis
  • Perform simultaneous measurements of thousands of proteins from a single panel

*Our proteomics technologies, including the advanced Olink and SomaLogic platforms, are designated for Research Use Only (RUO). They can be utilized for various research purposes, such as:

  • Retrospective analysis of clinical samples from an existing or previously closed clinical study and/or
  • Exploratory endpoint analysis within an existing clinical study or a clinical study still to be opened.

**Tailor your research with our customizable options; choose from eight specific 384-plex panels within the Explore 3072 library to focus on particular diseases and biological processes.

image description

Benefits of Tempus’ Omics Solutions

  • Streamlined Vendor Management

    With solutions throughout the clinical development and research process, Tempus can be your sole vendor.

  • Complete Solutions

    From sample extraction to data delivery, we accommodate various sample types and project needs.

  • High-Quality Data

    Trusted by over 200+ biopharma and over 50% of oncologists in the US, Tempus delivers robust data insights.

  • White Glove Project Management

    Receive real-time project updates from a dedicated project manager throughout the project’s duration.

  • Personalized Services

    Customizable and off-the-shelf assays tailored to your specific needs.

  • Expert Support

    Ph.D.-level analytical support for research and translational questions.

  • Automated Workflows

    Increased scalability and improved reproducibility.

  • Fast Turnaround

    Benefit from quick processing times and constant communication for project updates.

  • US-based Operations

    Reliable and efficient service with US-based state-of-the-art labs, processing, and customer support.

Integrating Omics in R&D: A new era of biomedical research

Learn how academic researchers across the country have utilized transformative multi-omics technology in understanding complex disease mechanisms from NGS to proteomics.

Watch now
Our Impact

It is great to have a familiar genomic service provider in Atlanta. [Tempus’ omics solutions] bring a lot of experience and has provided responsive and cost-effective methylation and gene expression profiling for us on multiple occasions.

Dr. Greg Gibson, Professor and Director, Center for Integrative Genomics, Georgia Institute of Technology

Our Impact

The UC Athena project is utilizing [Tempus’ omics solutions] expert capabilities to screen for genome variants in the context of cancer.

Dr. Laura van’t Veer, Professor and Endowed Chair in Cancer Research, Department of Laboratory Medicine, UCSF

Our Impact

We were attracted to [Tempus’ omics solutions] because of their outstanding quality and service-oriented approach as well as their know-how in molecular genetic technologies. The unique partnership with [Tempus’ omics solutions] will allow us to expand our comprehensive suite of services that have successfully supported the pharma market for nine years. Through this collaboration, we will be able to better serve all of our customers in the US, with the unmatched quality and value-added services that we have established over the past nine years.

Dr. Thomas Henkel, CEO of Targos

Our Impact

We are very pleased to be working with [Tempus’ omics solutions]. They are a leading provider of genetic technologies, with advanced capabilities, including next-generation forensic profiling solutions, and most importantly excellent service This combination is critical to advancing the future of forensic investigation. We have already achieved success in several of recent projects that we have completed together.

Dr. Laurence Rubin, CEO of Identitas

Our Impact

[Tempus’ omics solutions] is a leader in molecular genetic technologies, and is particularly known for its outstanding delivery of service.

Don Rule, CEO of Translational Software

Product and company names are trademarks of their respective holders. Use of them does not imply affiliation or endorsement.

Other Solutions for
Life Sciences

Partner with us

With a broad range of technologies and assays, we have the solutions you need.